Your browser doesn't support javascript.
loading
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
West, Alex; Chaudhuri, Nazia; Barczyk, Adam; Wilsher, Margaret L; Hopkins, Peter; Glaspole, Ian; Corte, Tamera Jo; Sterclová, Martina; Veale, Antony; Jassem, Ewa; Wijsenbeek, Marlies S; Grainge, Christopher; Piotrowski, Wojciech; Raghu, Ganesh; Shaffer, Michele L; Nair, Deepthi; Freeman, Lisa; Otto, Kelly; Montgomery, A Bruce.
Affiliation
  • West A; Guy's and St Thomas' Hospital, London, UK.
  • Chaudhuri N; University of Ulster, Magee Campus, Londonderry, UK.
  • Barczyk A; Department of Pneumonology, Medical University of Silesia, Katowice, Slaskie, Poland.
  • Wilsher ML; Respiratory Services, Auckland District Health Board, Auckland, New Zealand.
  • Hopkins P; The Prince Charles Hospital, Brisbane, Queensland, Australia.
  • Glaspole I; Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
  • Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Sterclová M; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.
  • Veale A; Department of Respiratory Medicine, Thomayer Hospital, Praha, Praha, Czech Republic.
  • Jassem E; Department of Respiratory Medicine, Queen Elizabeth Hospital, Woodville South, South Australia, Australia.
  • Wijsenbeek MS; Gdanski Uniwersytet Medyczny, Gdansk, Poland.
  • Grainge C; Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Piotrowski W; Hunter Medical Research Institute, University of Newcastle, New Castle, New South Wales, Australia.
  • Raghu G; Department of Pneumonology and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland.
  • Shaffer ML; CENTER for Interstitial Lung Diseases, University of Washington, Seattle, Washington, USA.
  • Nair D; Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Freeman L; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Otto K; Avalyn Pharma Inc, Seattle, Washington, USA.
  • Montgomery AB; Avalyn Pharma Inc, Seattle, Washington, USA.
Thorax ; 78(9): 882-889, 2023 09.
Article in En | MEDLINE | ID: mdl-36948586
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Anti-Inflammatory Agents, Non-Steroidal / Idiopathic Pulmonary Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Thorax Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Anti-Inflammatory Agents, Non-Steroidal / Idiopathic Pulmonary Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Thorax Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido